[Relation of C-reactive protein and coronary heart disease. Current knowledges]

Area of Science:

• Biomarkers and Inflammation
• Cardiovascular Disease Research

Context:

• C-reactive protein (CRP) initially identified as an inflammation marker in coronary heart disease (CHD).
• Growing recognition of CRP's role in clinical practice and research for cardiovascular conditions.

Purpose:

• To highlight the expanding clinical utility of CRP in managing CHD patients.
• To discuss the implications of recent findings, like the JUPITER trial, for risk stratification.
• To explore CRP as a potential therapeutic target in cardiovascular medicine.

Summary:

• CRP is increasingly vital for managing coronary heart disease (CHD).
• The JUPITER trial demonstrates CRP's effectiveness in intermediate-risk populations.
• Emerging evidence suggests CRP could be a target for novel therapeutic interventions.

Impact:

• Enhances clinical decision-making for CHD patients, particularly those at intermediate risk.
• Opens new avenues for therapeutic development targeting inflammation in cardiovascular disease.
• Supports the integration of inflammatory markers into routine cardiovascular risk assessment.